Denmark confirms excessive-pricing decision
Denmark’s Competition Appeals Tribunal has confirmed findings by the country’s antitrust authority that drug distributor CD Pharma abused its dominant position in the market for the distribution of a stimulant drug by raising its price by 2000%.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10